Research On Financing Of Start-up Period Of Biotech Start-ups

In the current era of the country's encouragement of innovation and entrepreneurship,strategic emerging industries such as biotechnology and bio-based new materials have ushered in the spring of development,and more and more entrepreneurs and startups will emerge.For companies in the early stages of starting a business,solving financing issues is crucial,and it is about the success of the startup.As an entrepreneur in the biotechnology industry,when I encountered financing difficulties,I also checked a large number of articles,and found that around this problem,scholars at home and abroad have conducted more research on financing for technology-based enterprises,but stood by the government There are many discussions on policy formulation or industry development.There are few in-depth studies on specific financing issues of enterprises.The theoretical and practical guidance is not strong.Therefore,it is of great theoretical and practical significance to conduct in-depth research on the financing problems of biotech startups in the early stage combined with specific companies.In order to deeply study the financing problems of technology-based startups in the start-up period,analyze the causes and propose solutions,this article focuses on Guangzhou E Biotechnology Company.The article first carefully combs the existing and venture financing issues,and then explains related theories,including information asymmetry theory,venture capital theory,and corporate financial growth cycle theory,as the theoretical basis for analyzing and solving problems.Secondly,it introduces the current situation of the company's industry financing and the company's basic situation.The core part of the article is based on the current status of financing,summing up the problems of insufficient financing,narrow financing channels,high financing costs,uncertain financial risks,and large funding gaps.Information asymmetry,strong asset specificity,insufficient credit guarantees,high operating risks,industry obedience,and resistance to new technologies have been analyzed for the causes of financing problems.Finally,for the financing problem of Guangzhou E Biotechnology Company,a strategy of combining internal and external sources of financing based on the use of funds and the difference in time is formulated.Broaden external financing channels and reduce financing costs;take measures from the three levels of talent,technology and management to improve the company's operating level and strengthen the company's internal financing capabilities.At the same time,participate in innovation and entrepreneurship events to open up financing channels,and strive for government policy subsidies and support And do a good job of risk control.Finally,the research contents and results of this paper are summarized,the shortcomings of the research are pointed out,and the prospects for future research are put forward.